Evaluating thiamine deficiency in patients with diabetes [1]

Diabetes and Vascular Disease Research

Volumn 3, Issue 2, 2006, Pages 120-121

  Jermendy, György ^a  

^a BAJCSY ZSILINSZKY HOSPITAL   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; SUPEROXIDE; TRANSKETOLASE;

ALCOHOLISM; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME ACTIVITY; GLUCOSE METABOLISM; HOSPITAL PATIENT; HUMAN; LETTER; PATHOGENESIS; RISK FACTOR; THIAMINE DEFICIENCY; VEGETARIAN;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; THIAMINE; THIAMINE DEFICIENCY; TRANSKETOLASE;

EID: 33750390770     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.3132/dvdr.2006.014     Document Type: Letter

References (11)

1. Hammes HR Du X, Edelstein D et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nature Med 2003;9:244-9.
2. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615-25.
3. Herve C, Beyne P, Letterom P, Delacoux E. Comparison of erythrocyte transketolase activity with thiamine phosphate ester levels in chronic-alcoholic patients. Clin Chim Acta 1995;234:91-100.
4. Pepersack T, Garbusinski J, Robberecht J, Beyer I, Willems D, Fuss M. Clinical relevance of thiamine status amongst hospitalized elderly patients. Gerontology 1999;45:96-101.
5. Shimon I, Almong S, Vered Z et al. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med 1995;98:485-90.
6. Saito N, Kimura M, Kuchiba A, Itokawa Y. Blood thiamine levels in outpatients with diabetes mellitus. J Nutr Sci Vitaminol (Tokyo) 1987;33:421-30.
7. Vuilleumier JP, Keller HE, Rettenmaier R, Hunziker F. Clinical chemical methods for the routine assessment of the vitamin status in human populations. Part II: The water-soluble vitamins B1, B2 and B6. Internat J Vit Nutr Res 1983;53:359-70.
8. Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley PJ. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 2003;52:2110-20.
9. Stracke H, Hammes HP, Werkmann D et al. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats. Exp Clin Endocrinol Diabetes 2001;109:330-6.
10. Haupt E, Ledermann H, Kopcke W. Benfotiamine in the treatment of diabetic polyneuropathy - three-week randomized, controlled pilot study (BEDIP study). Int J Clin Pharmacol Ther 2005;43:71-7.
11. Erratum in: Int J Clin Pharmacol Ther 2005;43:304.